Mesenchymal Stem Cells
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 13, 2026

Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation
Published on: July 23, 2012
Shao-Lin Zeng1, Li-Hui Wang1, Ping Li1
1Department of Respiratory Medicine, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430071, P.R. China.
Mesenchymal stem cells (MSCs) show promise for treating asthma by targeting airway dendritic cells (DCs). MSCs reduce DC maturation and migration, thereby suppressing the allergic T helper type 2 (Th2) immune response in asthma models.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: